INTEGRATED BIOPHARMA INC (INBP)

↓ Download CSV

CIK 0001016504 · OTC · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Jun 30

In fiscal 2025, INTEGRATED BIOPHARMA INC reported revenue of $54.35M, up 8.0% from the prior year. The company was profitable, with a net margin of 1.5% and a gross margin of 10.2%. It held $24.90M in total assets against $4.58M in total liabilities.

Key ratios (FY2025)

10.2%
Gross margin
3.7%
Operating margin
1.5%
Net margin
4.0%
Return on equity
+8.0%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$54.35M$50.32M$50.67M$56.25M$63.56M$52.77M$49.98M$43.71M
Cost of Revenue$48.79M$46.43M$46.61M$49.69M$54.08M$46.04M$43.76M$38.72M$40.29M
Gross Profit$5.56M$3.88M$4.06M$6.55M$9.48M$6.73M$6.22M$4.99M$6.67M$5.50M
Operating Income$2.02M$251.0K$120.0K$2.75M$5.78M$3.26M$2.70M$1.69M$3.19M$2.11M
Net Income$808.0K$112.0K-$34.0K$3.84M$8.01M$4.11M$1.69M$679.0K$2.35M$958.0K
EPS (Diluted)$0.03$0.00$0.00$0.12$0.25$0.13$0.06$0.02$0.10$0.05
Total Assets$24.90M$26.21M$25.43M$25.25M$25.44M$22.94M$19.79M$14.57M$15.20M$13.95M
Total Liabilities$4.58M$6.97M$6.57M$6.67M$11.11M$16.88M$17.90M$19.80M$21.12M$22.28M
Shareholders' Equity$20.32M$19.24M$18.86M$18.57M$14.33M$6.07M$1.89M-$5.24M-$5.93M-$8.33M
Cash & Equivalents$3.62M$1.68M$1.32M$331.0K$210.0K$402.0K$475.0K$228.0K$132.0K$395.0K
Operating Cash Flow$2.06M$943.0K$1.23M$4.09M$3.05M$1.34M$328.0K$1.17M$397.0K
Capital Expenditures$191.0K$553.0K$116.0K$486.0K$295.0K$214.0K$414.0K$247.0K$327.0K$109.0K
Shares Outstanding31.06M30.10M29.95M29.95M29.80M29.65M29.57M21.14M21.14M21.11M